FINAL PROGRAM The Movement Disorder Society’s 13th International Congress OF PARKINSon’S DISEASE AND MOVEMENT DISORDERS JUNE 7-11, 2009 Paris, France The Movement Disorder Society’s 13th International Congress of Parkinson’s Disease and Movement Disorders Claiming CME Credit To claim CME credit for your participation in the MDS 13th International Congress of Parkinson’s Disease and Movement Disorders, International Congress participants must complete and submit an online CME Request Form. This Form will be available beginning June 10. Instructions for claiming credit: • After June 10, visit www.movementdisorders.org/congress/congress09/cme • Log in following the instructions on the page. You will need your International Congress Reference Number, located on the upper right of the Confirmation Sheet found in your registration packet. • Follow the on-screen instructions to claim CME Credit for the sessions you attended. • You may print your certificate from your home or office, or save it as a PDF for your records. Continuing Medical Education The Movement Disorder Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation The Movement Disorder Society designates this educational activity for a maximum of 30.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Non-CME Certificates of Attendance were included with your on- site registration packet. If you did not receive one, please e-mail [email protected] to request one. The Movement Disorder Society has sought accreditation from the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. EACCME credits are recognized by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA. www.ama-assn.org/ama/pub/category/1438.html. 2 June 7-11, 2009 Paris, France TABLE OF CONTENTS Welcome Letter . 2 Acknowledgments . 3 About MDS . .4 Education Information . .7 Membership Information . .13 Map of Paris . .16 International Congress Information . 17 Speaker Ready Room Hours . 17 Poster Sessions Hours . .19 Social Events . .20 Le Palais des Congrès Floor Plans . 21 Awards Information . .23 CME Information . .28 Program-at-a-Glance . 30 Session Definitions . 31 Scientific Program . 32 Faculty Listing . 45 Corporate Therapeutic Symposia . .48 Exhibitor Information . 51 Exhibitor Directory . 52 Exhibit Hall Floor Plan . .59 Guided Poster Tours Information . 62 Abstract Listing by Topic . 68 1 The Movement Disorder Society’s 13th International Congress of Parkinson’s Disease and Movement Disorders WELCOME Dear Colleagues and Friends, Bonjour and welcome to Paris for the 13th International Congress of Parkinson’s Disease and Movement Disorders! Planning for this International Congress began more than a year ago. We would like to express our gratitude to the large number of our volunteer committees for designing this International Congress and we would especially like to thank the Congress Scientific Program Committee (CSPC) for their hard work and coordination of this superior Scientific Program. The 2009 Scientific Program will incorporate Therapeutic Plenary Sessions, Plenary and Parallel Sessions, Teaching Courses, Video Sessions, Skills Workshops, Posters sessions and Guided Poster Tours. This year’s program features 59 sessions led by over 170 esteemed faculty from around the world. We are presenting a record number of 1,693 abstracts in poster sessions over the course of four days. Although the city of Paris is one of the most popular tourist destinations in the world, we do hope that you will be able to allot time in your schedule to participate in our detailed program, visit the Exhibit Area and poster areas, and attend the social events in the evenings. We would also like to thank the members of the Congress Local Organizing Committee for their hard work in arranging the Congress social events that we are sure you will enjoy. For the first year, the CSPC has selected a group of sessions on a specific theme allowing participants of theM DS International Congress to have an educational and comprehensive overview on a subject of broad interest to our community. For the 2009 meeting the selected topic is “Anatomy, physiology and pathology of the basal ganglia.” At the end of the meeting the participants to these sessions should be able to have a more complete understanding of the basal ganglia function. These sessions are designated with a . Thank you for your support of The Movement Disorder Society and welcome to our 13th International Congress of Parkinson’s Disease and Movement Disorders. With kind regards, Anthony E. Lang Serge Przedborski President, The Movement Chair, Congress Scientific Disorder Society, 2007-2009 Program Committee, 2008-2009 Etienne Hirsch Olivier Rascol Marie Vidailhet Co-Chair, Congress Scientific Co-Chair, Congress Scientific Co-Chair, Congress Local Program Committee, 2009 Program Committee, 2009 Organizing Committee, 2009 Co-Chair, Congress Local Organizing Committee, 2009 2 June 7-11, 2009 Paris, France AcKNOWLEDGMENTS The International Congress Oversight Committee of the 13th International Congress of Parkinson’s Disease and Movement Disorders wishes to acknowledge and thank the following companies for their support: DOUBLE PLATINUM LEVEL PLATINUM PLUS LEVEL PLATINUM LEVEL GOLD LEVEL SILVER LEVEL *These supporters are confirmed as of April 15, 2009 3 The Movement Disorder Society’s 13th International Congress of Parkinson’s Disease and Movement Disorders ABOUT MDS The Movement Disorder Society (MDS) is an Mission and Goals: nformation international, professional society of clinicians, To disseminate knowledge about Movement I S scientists, and other healthcare professionals Disorders by: who are interested in Parkinson’s disease, related • Providing educational programs for clinicians, MD neurodegenerative and neurodevelopmental scientists and the general public designed to disorders, hyperkinetic Movement Disorders, and advance scientific and clinical knowledge about abnormalities in muscle tone and motor control. Movement Disorders The spectrum of clinical disorders represented by • Sponsoring congresses and symposia on the Society includes, but is not limited to: Movement Disorders Ataxia • Collaborating with other international Blepharospasm organizations and lay groups Dysphonia • Publishing journals, videotapes and other Dystonic disorders collateral materials committed to high scientific Gait disorders standards and peer review Huntington’s disease To promote research into causes, prevention and Myoclonus treatment of Movement Disorders by: Parkinson’s disease • Using the Society’s influence and resources to Restless legs syndrome enhance support for research Spasticity • Facilitating the dissemination of information Tardive dyskinesia about research Tics and Tourette syndrome • Encouraging the training of basic and Tremor clinical scientists in Movement Disorders and related disorders The Movement Disorder Society (MDS) was To formulate and promote public policy that will founded in 1985 on the initiative of Professors favorably affect the care of patients with Movement Stanley Fahn and C. David Marsden, whose Disorders by: leadership and vision guided the expansion of • Working with regulatory agencies to assist them clinical expertise and research in this field. The in the approval process of safe and effective organization merged in 1988 with the International therapeutic interventions Medical Society for Motor Disturbances. • Informing the public (media) and patient support groups of new research and therapeutic advances Purpose, Mission and Goals • Playing a proactive role in the development Purpose: of policies that affect support of research and The object and mission of the Society shall be to patient care advance the neurological sciences pertaining to • Developing standards of training in Movement Disorders; to operate exclusively for the specialty scientific, scholarly and educational purposes; to encourage research; to provide forums, such as medical journals, scientific symposia and International Congresses, for sharing ideas and advancing the related clinical and scientific disciplines; to encourage interest and participation in the activities of the Society among healthcare and allied professionals and scientists; and to collaborate with other related professional and lay organizations. 4 June 7-11, 2009 Paris, France MD ABOUT MDS S I MDS Officers nformation President President-Elect Secretary Secretary-Elect Treasurer Treasurer-Elect Past-President Anthony E. Lang, Philip Thompson, Olivier Rascol, Matthew Stern, Yoshikuni Oscar Gershanik, Andrew Lees, Canada Australia France USA Mizuno, Argentina United Kingdom Japan MDS International Executive Committee Congress Scientific Program Committee Giovanni Abbruzzese, Italy Chair: Serge Przedborski, USA Alim L. Benabid, France Co-Chair 2009: Etienne Hirsch, France Shu-Leong Ho, Hong Kong Co-Chair 2009: Olivier Rascol, France Karl Kieburtz, USA Cynthia Comella, USA Irene Litvan, USA Ted Dawson, USA Demetrius Maraganore, USA Günther Deuschl, Germany Marcelo Merello, Argentina Dennis Dickson, USA John Rothwell, United Kingdom